Literature DB >> 24608314

The microbiome and diverticulitis: a new target for medical therapy?

Jason F Hall1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24608314     DOI： 10.1097/DCR.0000000000000077

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  4 in total

1.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.

Authors:  Charlotte L Kvasnovsky; Ingvar Bjarnason; Ana Nora Donaldson; Roy A Sherwood; Savvas Papagrigoriadis
Journal:  Inflammopharmacology       Date:  2017-05-20       Impact factor: 4.473

2.  The role of body composition in diverticular disease.

Authors:  Julia Freckelton; Darcy Holt; Adina Borsaru; StellaMay Gwini; Daniel Croagh; Gregory Moore
Journal:  Int J Colorectal Dis       Date:  2018-04-18       Impact factor: 2.571

3.  Diverticular disease epidemiology: acute hospitalisations are growing fastest in young men.

Authors:  J B Broad; Z Wu; S Xie; I P Bissett; M J Connolly
Journal:  Tech Coloproctol       Date:  2019-08-08       Impact factor: 3.781

Review 4.  Pathophysiology and Epidemiology of Diverticular Disease.

Authors:  Stephanie D Talutis; F Angela H Kuhnen
Journal:  Clin Colon Rectal Surg       Date:  2020-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.